Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas. Preliminary results of a phase II, single-institutional trial

This study aims to asses the effectiveness and toxicity of boost radiotherapy concomitant and concurrent cisplatin for patients with locally advanced head and neck cancer (LAHNC). There were 30 patients included in a prospective, phase II single-institution trial and of whom, 29 were at AJCC stage I...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical & translational oncology 2005-03, Vol.7 (2), p.60-65
Hauptverfasser:	Arias de la Vega, Fernando, Domínguez Domínguez, Miguel Angel, Manterola Burgaleta, Ana, Vera García, Ruth, Echeverría Zabalza, Maria Eugenia, Oria Mundin, Eugenio, Martínez López, Enrique, Romero Rojano, Pilar, Villafranca Iture, Elena
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - therapeutic use Cisplatin - therapeutic use Combined Modality Therapy Disease Progression Female Head and Neck Neoplasms - drug therapy Head and Neck Neoplasms - pathology Head and Neck Neoplasms - radiotherapy Humans Male Middle Aged Prospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!